8 comments

[ 3.3 ms ] story [ 15.4 ms ] thread
And I still have no idea what this startup does, its plans, or how it operates. I expect more from WSJ
It's a direct-to-consumer pharmacy company, IIRC. The story says it started out with ED pills and hair loss pills, and based on the image of an advertisement, it looks like they now do weight loss (Ozempic?) medication as well.

As for the opacity of the WSJ piece, it's apparently a new feature that focuses on CEOs themselves: "A new Wall Street Journal feature in which executives reflect on the successes and setbacks of their careers."

You weren't supposed to read the article; only the wacky headline.

The article was obviously generated by AI.

In case it’s not clear what the company does, here’s another article [0] with an interesting quote:

> “Every time I’m stressed out about work, I come back to the same realization: we’re selling dick pills, we’re not curing cancer, we’re not becoming a patient’s first call,” a current employee told TechCrunch. “[Erectile dysfunction] is where we make all our money.”

[0] https://techcrunch.com/2021/10/27/ro/

Is Roman still worth $7bn?
Probably $10bn now after I bought 1/10 billionth of the company for $1